Kimberly Wehger
Chief Tech/Sci/R&D Officer at ARVINAS, INC.
Profile
Kimberly Wehger is Vice President-Information Technology at Arvinas, Inc. In the past Ms. Wehger was Chief Information Officer & Vice President at New Haven Pharmaceuticals, Inc., Director-Business Engagement at Alexion Pharmaceuticals, Inc. and Practice Manager-R&D Managed Services at Veeva Systems, Inc. She received an undergraduate degree from State University of New York at Binghamton and a graduate degree from Southern Connecticut State University.
Kimberly Wehger active positions
Companies | Position | Start |
---|---|---|
ARVINAS, INC. | Chief Tech/Sci/R&D Officer | - |
Former positions of Kimberly Wehger
Companies | Position | End |
---|---|---|
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Chief Tech/Sci/R&D Officer | 2015-12-31 |
ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
VEEVA SYSTEMS INC. | Corporate Officer/Principal | - |
Training of Kimberly Wehger
Southern Connecticut State University | Graduate Degree |
State University of New York at Binghamton | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
VEEVA SYSTEMS INC. | Technology Services |
ARVINAS, INC. | Health Technology |
Private companies | 2 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Health Technology |
- Stock Market
- Insiders
- Kimberly Wehger